Storyline
Fierce’s "the top line" revisits notable clinical trial failures from 2025
Fierce Biotech highlights a new episode of "The Top Line" in which James Waldron (Fierce Biotech) and Fraiser Kansteiner (Fierce Pharma) review the clinical trial failures that stood out in 2025 and discuss what those setbacks may suggest about ongoing challenges in drug development.
Current brief openSource links open
This current storyline is open here with summary, metadata, source links, continuity context, and full evidence. Paid is for compare-over-time, alerts, exports, and workflow.
No card needed for the free brief.
Evidence trail (top sources)
top sources (1 domains)domains are deduped. counts indicate coverage, not truth.1 top source shown
limited source diversity in top sources
Overview
Fierce Biotech highlights a new episode of "The Top Line" in which James Waldron (Fierce Biotech) and Fraiser Kansteiner (Fierce Pharma) review the clinical trial failures that stood out in 2025 and discuss what those setbacks may suggest about ongoing challenges in drug development.
Score total
1.3
Momentum 24h
2
Posts
2
Origins
2
Source types
2
Duplicate ratio
0%
Why now
- A newly published "The Top Line" episode and companion post recap 2025 failures
- The discussion explicitly links 2025 setbacks to broader drug development challenges
Why it matters
- Trial failures can reset R&D priorities and risk assumptions across drug development
- Post-mortems can surface recurring scientific or execution pitfalls
- Year-in-review framing helps contextualize setbacks beyond single programs
Continuity snapshot
- Trend status: insufficient_history.
- Continuity stage: emerging_confirmed.
- Current status: open.
- 2 current source-linked posts are attached to this storyline.
All evidence
All evidence
On this episode of "The Top Line," Fierce Biotech's James Waldron and Fierce Pharma's Fraiser Kansteiner discuss the clinical trial failures that stood out in 2025. https://omn...
FierceBiotech · omny.fm · 2026-02-13 17:22 UTC
On this episode of "The Top Line," Fierce Biotech's James Waldron and Fierce Pharma's Fraiser Kansteiner discuss the clinical trial failures that stood out in 2025 and what they...
Fierce Biotech · fiercebiotech.com · 2026-02-13 17:11 UTC
Show filters & breakdown
Posts loaded: 0Publishers: 2Origin domains: 2Duplicates: -
Showing 2 / 0
Top publishers (this list)
- FierceBiotech (1)
- Fierce Biotech (1)
Top origin domains (this list)
- omny.fm (1)
- fiercebiotech.com (1)